Techcyte, Conflux add AI-native reporting to digital pathology workflow

Techcyte and Conflux announced a partnership on August 11, 2026, to embed Conflux directly into the Techcyte Fusion digital pathology platform. The integration is designed to let pathologists dictate, edit and structure reports without leaving the case review screen, cutting context switching and manual cleanup.

Why it matters: - The integration aims to speed up pathology reporting while keeping the pathologist focused on slides and case review. - Techcyte and Conflux are targeting a workflow that connects interpretation, structured reporting and downstream actions in one environment. - The move could reduce manual editing, transcription errors and context switching in digital pathology.

What happened: - Techcyte and Conflux announced a partnership on August 11, 2026, in Orem, Utah. - Conflux will be integrated directly into the Techcyte Fusion digital pathology platform. - The integration is embedded within Fusion AP, placing report creation alongside the active case.

The details: - Pathologists can dictate reports, use natural-language instructions to change report content, and complete structured reporting workflows without leaving Fusion. - Conflux is built for pathology and offers low-latency dictation for medical terminology, measurements, specimen identifiers and report formatting. - Case and reporting context help identify intended terminology and correct common transcription errors in real time. - Each reportable element is verified by the pathologist and includes a reference to its source. - Commands such as “set all parts to normal” can update the right report sections based on specimen and context. - Existing templates, macros, dot phrases and snippet libraries can be imported and triggered by voice or typing. - The system preserves familiar workflows while adapting content to the active case, specimen or report section. - Fusion AP synchronizes dictation controls, follows display preferences and incorporates relevant case information, findings and annotations into the report. - The integration can help populate structured report elements and surface relevant guidelines and staging criteria. - Pathologists remain in control of the final report. - Techcyte’s anatomic and clinical pathology platform is for Research Use Only in the United States.

Between the lines: - Techcyte is positioning Fusion as an open platform that can pull in specialized tools rather than forcing users into a closed reporting system. - Conflux is pushing beyond transcription into guided reporting, which could matter more as pathology workflows become more structured and data-driven. - The partnership suggests a longer-term bet on linking what pathologists see, say and decide with downstream reporting and laboratory systems.

What's next: - Techcyte and Conflux say the integration should reduce context switching now and support more connected workflows over time. - The companies expect the combined environment to make report creation faster and more natural for pathologists. - Conflux’s broader roadmap points to workflows that connect case context, reporting, evidence, coding and downstream laboratory systems.

The bottom line: - Techcyte and Conflux are trying to turn pathology reporting into an AI-assisted, case-aware workflow instead of a separate clerical step. - The partnership centers on keeping reporting tied to the slide review process while preserving pathologist control.